–
NeuroSense Therapeutics Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−2.99
FY22:
−10.6
FY23:
−12.0
FY24:
−9.90
FY25:
−11.1
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−14.2
FY24:
−9.88
FY25:
−11.0
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−10.1
FY24:
−10.2
FY25:
−11.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.22
FY22:
−10.5
FY23:
−10.1
FY24:
−10.2
FY25:
−11.1
All amounts in millions USD